Structure and signalling in the IL-17 receptor family
Open accessThe DOI matches its Crossref record; 111 of the 111 references it cites were found in a registry or an index.
Abstract
Interleukin-17A (IL-17A), the hallmark cytokine of the newly defined T helper 17 (T(H)17) cell subset, has important roles in protecting the host against extracellular pathogens, but also promotes inflammatory pathology in autoimmune disease. IL-17A and its receptor (IL-17RA) are the founding members of a newly described family of cytokines and receptors that have unique structural features which distinguish them from other cytokine families. Research defining the signal transduction pathways induced by IL-17R family cytokines has lagged behind that of other cytokine families, but studies in the past 2 years have begun to delineate unusual functional motifs and new proximal signalling mediators used by the IL-17R family to mediate downstream events.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“most documented IL-17R signaling occurs in non-hematopoietic cells, particularly cells of epithelial and mesenchymal origin [44,45].”
From The Kallikrein-Kinin System: A Novel Mediator of IL-17-Driven Anti-Candida Immunity in the Kidney (2016) · cites this paper as [44]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mosmann, T. R., Cherwinski, H., Bond, M. W., Giedlin, M. A., & Coffman, R. L. (1986) · The Journal of Immunology · doi:10.4049/jimmunol.136.7.2348 · Cited by 7,506
Bettelli, E., Carrier, Y., Gao, W., Korn, T., Strom, T. B., Oukka, M., Weiner, H. L., & Kuchroo, V. K. (2006) · Nature · doi:10.1038/nature04753 · Cited by 6,992
Ivanov, I. I., McKenzie, B. S., Zhou, L., Tadokoro, C. E., Lepelley, A., Lafaille, J. J., Cua, D. J., & Littman, D. R. (2006) · Cell · doi:10.1016/j.cell.2006.07.035 · Cited by 5,145
Harrington, L. E., Hatton, R. D., Mangan, P. R., Turner, H., Murphy, T. L., Murphy, K. M., & Weaver, C. T. (2005) · Nature Immunology · doi:10.1038/ni1254 · Cited by 4,742
A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17
Park, H., Li, Z., Yang, X. O., Chang, S. H., Nurieva, R., Wang, Y.-H., Wang, Y., Hood, L., Zhu, Z., Tian, Q., et al. (2005) · Nature Immunology · doi:10.1038/ni1261 · Cited by 4,265
IL-23 drives a pathogenic T cell population that induces autoimmune inflammation
Langrish, C. L., Chen, Y., Blumenschein, W. M., Mattson, J., Basham, B., Sedgwick, J. D., McClanahan, T., Kastelein, R. A., & Cua, D. J. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041257 · Cited by 4,099
Veldhoen, M., Hocking, R. J., Atkins, C. J., Locksley, R. M., & Stockinger, B. (2006) · Immunity · doi:10.1016/j.immuni.2006.01.001 · Cited by 3,605
Transforming growth factor-β induces development of the TH17 lineage
Mangan, P. R., Harrington, L. E., O'Quinn, D. B., Helms, W. S., Bullard, D. C., Elson, C. O., Hatton, R. D., Wahl, S. M., Schoeb, T. R., & Weaver, C. T. (2006) · Nature · doi:10.1038/nature04754 · Cited by 3,087
A Genome-Wide Association Study Identifies IL23R as an Inflammatory Bowel Disease Gene
Duerr, R. H., Taylor, K. D., Brant, S. R., Rioux, J. D., Silverberg, M. S., Daly, M. J., Steinhart, A. H., Abraham, C., Regueiro, M., Griffiths, A., et al. (2006) · Science · doi:10.1126/science.1135245 · Cited by 3,039
Cua, D. J., Sherlock, J., Chen, Y., Murphy, C. A., Joyce, B., Seymour, B., Lucian, L., To, W., Kwan, S., Churakova, T., et al. (2003) · Nature · doi:10.1038/nature01355 · Cited by 2,906
Cited by
Items 101–200 of 1,001
Directing traffic: IL‐17 and IL‐22 coordinate pulmonary immune defense
McAleer, J. P., & Kolls, J. K. (2014) · Immunological Reviews · doi:10.1111/imr.12183 · Cited by 194
“The IL-17 receptor (IL-17R) family comprises five members that function as heteromeric complexes (83).”
Backgroundand the IBSEN study group, Franke, A., Balschun, T., Sina, C., Ellinghaus, D., Häsler, R., Mayr, G., Albrecht, M., Wittig, M., Buchert, E., et al. (2010) · Nature Genetics · doi:10.1038/ng.553 · Cited by 194
Bimekizumab, a Novel Humanized IgG1 Antibody That Neutralizes Both IL-17A and IL-17F
Adams, R., Maroof, A., Baker, T., Lawson, A. D. G., Oliver, R., Paveley, R., Rapecki, S., Shaw, S., Vajjah, P., West, S., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01894 · Cited by 188
“Expressed as homodimers, or as a heterodimer (IL-17A/F) (8, 9), both IL-17A and IL-17F signal through the same heterodimeric complex of IL-17 receptors A and C (IL-17RA/RC) (10).”
BackgroundInnovation in the treatment of atopic dermatitis: Emerging topical and oral Janus kinase inhibitors
Nakashima, C., Yanagihara, S., & Otsuka, A. (2022) · Allergology International · doi:10.1016/j.alit.2021.10.004 · Cited by 192
Inflammatory Bowel Disease: A Review of Pre-Clinical Murine Models of Human Disease
Katsandegwaza, B., Horsnell, W., & Smith, K. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23169344 · Cited by 185
“Both the IL-17 family members IL-17A and IL-17F coordinate local tissue inflammation by regulating the release of proinflammatory cytokines and the recruitment of neutrophils [76].”
Inherited IL-17RC deficiency in patients with chronic mucocutaneous candidiasis
Ling, Y., Cypowyj, S., Aytekin, C., Galicchio, M., Camcioglu, Y., Nepesov, S., Ikinciogullari, A., Dogu, F., Belkadi, A., Levy, R., et al. (2015) · Journal of Experimental Medicine · doi:10.1084/jem.20141065 · Cited by 192
“…five members of the IL-17 receptor family, is a key component of the IL-17A and IL-17F receptor, as it forms a heterotrimeric receptor complex together with IL-17RA (Moseley et al., 2003; Toy et al., 2006; Weaver et al., 2007; Ely et al., 2009; Gaffen, 2009; Ho and Gaffen, 2010; Ho et al., 2010).”
BackgroundThe IL-23/IL-17 axis in psoriatic arthritis
Suzuki, E., Mellins, E. D., Gershwin, M. E., Nestle, F. O., & Adamopoulos, I. E. (2014) · Autoimmunity Reviews · doi:10.1016/j.autrev.2014.01.050 · Cited by 186
“IL-17 binds IL-17R (IL-17RA/IL-17RC), which is expressed by various cells such as monocytes, lymphocytes, lymphoid tissue inducer cells, epithelial cells, synoviocytes, fibroblasts and keratinocytes [26,27] (Fig.”
BackgroundBeurel, E., & Lowell, J. A. (2018) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2017.08.001 · Cited by 187
IL-17 in obesity and adipogenesis
Ahmed, M., & Gaffen, S. L. (2010) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2010.10.005 · Cited by 185
Self-citationSong, X., Gao, H., Lin, Y., Yao, Y., Zhu, S., Wang, J., Liu, Y., Yao, X., Meng, G., Shen, N., et al. (2014) · Immunity · doi:10.1016/j.immuni.2013.11.018 · Cited by 185
“Similarly, IL-17RE deficiency led to reduced cell survival and the expression of the survival genes at a late stage , January 16, 2014 ª2014 Elsevier Inc. 143 of tumor development (at the age of 20 weeks) in Apcmin/+ mice (Figures S3E–S3H).”
BackgroundInfluentialChong, W. P., Mattapallil, M. J., Raychaudhuri, K., Bing, S. J., Wu, S., Zhong, Y., Wang, W., Chen, Z., Silver, P. B., Jittayasothorn, Y., et al. (2020) · Immunity · doi:10.1016/j.immuni.2020.06.022 · Cited by 184
“IL-17A induces inflammation and causes tissue damage by (1) activating nuclear factor kappa light-chain enhancer of activated B cells (NF-kB) signaling to enhance production of inflammatory molecules and (2) recruiting different types of immune cells into inflamed tissues (Gaffen, 2009).”
BackgroundInfluentialIL‐17: overview and role in oral immunity and microbiome
Abusleme, L., & Moutsopoulos, N. (2017) · Oral Diseases · doi:10.1111/odi.12598 · Cited by 183
Cardiac fibroblasts mediate IL-17A–driven inflammatory dilated cardiomyopathy
Wu, L., Ong, S., Talor, M. V., Barin, J. G., Baldeviano, G. C., Kass, D. A., Bedja, D., Zhang, H., Sheikh, A., Margolick, J. B., et al. (2014) · Journal of Experimental Medicine · doi:10.1084/jem.20132126 · Cited by 181
“IL17A signals through the classical NFB pathway, which requires the degradation of NFB inhibitor IB (Gaffen, 2009).”
BackgroundInfluentialIL-17 Induces an Expanded Range of Downstream Genes in Reconstituted Human Epidermis Model
Chiricozzi, A., Nograles, K. E., Johnson-Huang, L. M., Fuentes-Duculan, J., Cardinale, I., Bonifacio, K. M., Gulati, N., Mitsui, H., Guttman-Yassky, E., Suárez-Fariñas, M., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0090284 · Cited by 180
“IL-17 signaling activates the Nuclear factor kappalight-chain-enhancer of activated B cells (NF-kB) pathway and the C/CAAT-enhancer-binding proteins (C/EBP) family, particularly C/EBPb and C/EBPd [7,8] to enhance expression of pro- inflammatory cytokines and chemokines, intercellular adhesion molecules, and anti-micro…”
BackgroundThe role of Th17 cytokines in primary mucosal immunity
Kolls, J. K., & Khader, S. A. (2010) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2010.11.002 · Cited by 176
“This receptor can bind at least three members of the IL-17 family including IL-17A, the closely related molecule IL-17F, as well as the most distally related IL-17 family member IL-17E [17].”
BackgroundSecukinumab: a review of the anti-IL-17A biologic for the treatment of psoriasis
Frieder, J., Kivelevitch, D., & Menter, A. (2018) · Therapeutic Advances in Chronic Disease · doi:10.1177/2040622317738910 · Cited by 177
MacMahon Copas, A. N., McComish, S. F., Fletcher, J. M., & Caldwell, M. A. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.666737 · Cited by 173
Interleukin-17 cytokines are critical in development of fatal lupus glomerulonephritis
Pisitkun, P., Ha, H.-L., Wang, H., Claudio, E., Tivy, C. C., Zhou, H., Mayadas, T. N., Illei, G. G., & Siebenlist, U. (2012) · Immunity · doi:10.1016/j.immuni.2012.08.014 · Cited by 174
Human IL-31 is induced by IL-4 and promotes TH2-driven inflammation
Stott, B., Lavender, P., Lehmann, S., Pennino, D., Durham, S., & Schmidt-Weber, C. B. (2013) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.03.050 · Cited by 174
Interleukin-17 in human inflammatory diseases
Shabgah, A. G., Fattahi, E., & Shahneh, F. Z. (2014) · Advances in Dermatology and Allergology · doi:10.5114/pdia.2014.40954 · Cited by 174
High expression of IL-17 and IL-17RE associate with poor prognosis of hepatocellular carcinoma
Liao, R., Sun, J., Wu, H., Yi, Y., Wang, J.-X., He, H.-W., Cai, X.-Y., Zhou, J., Cheng, Y.-F., Fan, J., et al. (2013) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/1756-9966-32-3 · Cited by 173
“In contrast to IL-17RA, IL-17RC expression was much weaker in both peritumoral and intratumoral tissues, although it was identified as a receptor of IL-17, pairing with IL-17RA to induce responses to IL-17 [24].”
BackgroundLévy, R., Okada, S., Béziat, V., Moriya, K., Liu, C., Chai, L. Y. A., Migaud, M., Hauck, F., Al Ali, A., Cyrus, C., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1618300114 · Cited by 174
The Potential Role of Interleukin-17 in Severe Asthma
Wang, Y.-H., & Wills-Karp, M. (2011) · Current Allergy and Asthma Reports · doi:10.1007/s11882-011-0210-y · Cited by 171
“The homotypic interaction between IL-17RA and ACT1 through the SEFIR domain recruits tumor necrosis factor (TNF) receptor–associated factor 6, which activates downstream canonical nuclear factor-κB and mitogen-activated protein kinase pathways [18].”
BackgroundTeng, X., Hu, Z., Wei, X., Wang, Z., Guan, T., Liu, N., Liu, X., Ye, N., Deng, G., Luo, C., et al. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1300047 · Cited by 169
“In other studies, Smad3 antagonized C/EBP-STAT3 transcriptional activation and, thereby, suppressed IL-6 production and blocked the IL-17A–signaling pathways (25, 26).”
BackgroundImmunity to infection in IL‐17‐deficient mice and humans
Cypowyj, S., Picard, C., Maródi, L., Casanova, J., & Puel, A. (2012) · European Journal of Immunology · doi:10.1002/eji.201242605 · Cited by 168
Van Maele, L., Carnoy, C., Cayet, D., Ivanov, S., Porte, R., Deruy, E., Chabalgoity, J. A., Renauld, J.-C., Eberl, G., Benecke, A. G., et al. (2014) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiu106 · Cited by 168
Inflammatory bowel disease: exploring gut pathophysiology for novel therapeutic targets
Yadav, V., Varum, F., Bravo, R., Furrer, E., Bojic, D., & Basit, A. W. (2016) · Translational Research · doi:10.1016/j.trsl.2016.04.009 · Cited by 168
Hypomethylation of the IL17RC Promoter Associates with Age-Related Macular Degeneration
Wei, L., Liu, B., Tuo, J., Shen, D., Chen, P., Li, Z., Liu, X., Ni, J., Dagur, P., Sen, H. N., et al. (2012) · Cell Reports · doi:10.1016/j.celrep.2012.10.013 · Cited by 167
“Recent studies have suggested that high levels of IL-17RC expression are found in prostate cancer cells, as well as in synoviocytes andPBMCs frompatientswith rheumatoid arthritis (Gaffen, 2009).”
Cytokines and costimulation in acute graft-versus-host disease
Hill, G. R., & Koyama, M. (2020) · Blood · doi:10.1182/blood.2019000952 · Cited by 164
Pathogenic Role of IL-17-Producing Immune Cells in Obesity, and Related Inflammatory Diseases
Chehimi, M., Vidal, H., & Eljaafari, A. (2017) · Journal of Clinical Medicine · doi:10.3390/jcm6070068 · Cited by 166
“IL-17RA ubiquitous expression may account for the potential propagation of IL-17-mediated inflammation [12].”
BackgroundGenetics of ulcerative colitis
Thompson, A. I., & Lees, C. W. (2011) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21375 · Cited by 165
“It is speculated that IL17REL may oligomerize and bind specific IL17 cytokines, due to substantial homology with the extracellular receptor domains of IL17RE.(183) Inflamm Bowel Dis Volume 17, Number 3, March 2011 Genetics of UC”
BackgroundButcher, M. J., Gjurich, B. N., Phillips, T., & Galkina, E. V. (2012) · Circulation Research · doi:10.1161/circresaha.111.261784 · Cited by 165
Pan, B., Shen, J., Cao, J., Zhou, Y., Shang, L., Jin, S., Cao, S., Che, D., Liu, F., & Yu, Y. (2015) · Scientific Reports · doi:10.1038/srep16053 · Cited by 165
Robert, M., & Miossec, P. (2019) · Frontiers in Medicine · doi:10.3389/fmed.2018.00364 · Cited by 165
“The IL-17 receptor (IL-17R) family now includes 5 subunits, from IL-17RA to IL-17RE (26).”
BackgroundThe Th17 immune response in renal inflammation
Turner, J.-E., Paust, H.-J., Steinmetz, O. M., & Panzer, U. (2010) · Kidney International · doi:10.1038/ki.2010.102 · Cited by 164
Chen, K., & Kolls, J. K. (2017) · Gene · doi:10.1016/j.gene.2017.01.016 · Cited by 164
“Based on this more restricted expression of IL-17RC, it is thought that fibroblasts, epithelial cells and endothelial cells are a major target of IL-17A and IL-17F and targeting IL-17RC could be beneficial to the patients with a better specificity and selectivity.”
BackgroundMethodInfluentialIL-17 family cytokines mediated signaling in the pathogenesis of inflammatory diseases
Song, X., & Qian, Y. (2013) · Cellular Signalling · doi:10.1016/j.cellsig.2013.07.021 · Cited by 162
Attenuated atherosclerosis upon IL-17R signaling disruption in LDLr deficient mice
van Es, T., van Puijvelde, G. H. M., Ramos, O. H., Segers, F. M. E., Joosten, L. A., van den Berg, W. B., Michon, I. M., de Vos, P., van Berkel, T. J. C., & Kuiper, J. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.07.152 · Cited by 163
Role of immune cells in hypertension
Caillon, A., Paradis, P., & Schiffrin, E. L. (2019) · British Journal of Pharmacology · doi:10.1111/bph.14427 · Cited by 163
“IL-17A belongs to a group of six isoforms (A–F), of which IL-17A and IL-17F are the most closely related and generally produced by the same cells (Gaffen, 2009).”
BackgroundPsoriasis, psoriatic arthritis, and rheumatoid arthritis: Is all inflammation the same?
Coates, L. C., FitzGerald, O., Helliwell, P. S., & Paul, C. (2016) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2016.05.012 · Cited by 161
“Our understanding of psoriasis, psoriatic arthritis, and rheumatoid arthritis reveals distinct differences between these diseases in their pathogenesis [32,34,37,38], co-morbidities, and treatment strategies [6,70,105,154,163–166].”
BackgroundLuo, H., Liu, H.-Z., Zhang, W.-W., Matsuda, M., Lv, N., Chen, G., Xu, Z.-Z., & Zhang, Y.-Q. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.10.085 · Cited by 162
“The IL-17 family consists of six ligands (IL-17A–IL-17F) and five receptors (IL17RA–IL-17RE) in mammals (Gaffen, 2009).”
BackgroundIL-17 targeted therapies for psoriasis
Chiricozzi, A., & Krueger, J. G. (2013) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2013.806483 · Cited by 160
“The biologically active form of IL-17A consists of either disulfide-linked homodimers or IL-17A--IL-17F heterodimers [30,31].”
Novel therapeutic targets in rheumatoid arthritis
Koenders, M. I., & van den Berg, W. B. (2015) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2015.02.001 · Cited by 159
IL-17 in the immunopathogenesis of spondyloarthritis
Taams, L. S., Steel, K. J. A., Srenathan, U., Burns, L. A., & Kirkham, B. W. (2018) · Nature Reviews Rheumatology · doi:10.1038/s41584-018-0044-2 · Cited by 158
IL-25 (IL-17E) in epithelial immunology and pathophysiology
Borowczyk, J., Shutova, M., Brembilla, N. C., & Boehncke, W.-H. (2021) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2020.12.628 · Cited by 158
The sterile immune response during hepatic ischemia/reperfusion
van Golen, R. F., van Gulik, T. M., & Heger, M. (2012) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2012.04.006 · Cited by 175
Psoriasis: From Pathogenesis to Pharmacological and Nano-Technological-Based Therapeutics
Petit, R. G., Cano, A. C., Ortiz, A., Espina, M., Prat, J., Muñoz-Mateu, M., Severino, P. B., Souto, E. B., García, M. L., Pujol, M., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094983 · Cited by 195
“Th1 and Th2 cytokines act through Janus kinase (JAK)-STAT signalling pathways, whereas Th17 responses are mediated by ACT1 and NFκB [21].”
BackgroundCochaud, S., Giustiniani, J., Thomas, C., Laprevotte, E., Garbar, C., Savoye, A.-M., Curé, H., Mascaux, C., Alberici, G., Bonnefoy, N., et al. (2013) · Scientific Reports · doi:10.1038/srep03456 · Cited by 156
IL-17 in inflammatory skin diseases psoriasis and hidradenitis suppurativa
Fletcher, J. M., Moran, B., Petrasca, A., & Smith, C. M. (2020) · Clinical and Experimental Immunology · doi:10.1111/cei.13449 · Cited by 154
IL-17 Enhancement of the IL-6 Signaling Cascade in Astrocytes
Ma, X., Reynolds, S. L., Baker, B. J., Li, X., Benveniste, E. N., & Qin, H. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000142 · Cited by 154
“IL-17RA and IL-17RC are expressed in most tissues examined to date, and functional IL-17RA is expressed in CNS glia; however, little is known about the expression of IL-17RC in glial cells (26, 42).”
BackgroundInfluentialPsoriasis: rationale for targeting interleukin-17
Girolomoni, G., Mrowietz, U., & Paul, C. F. (2012) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2012.11099.x · Cited by 172
Host responses to Candida albicans: Th17 cells and mucosal candidiasis
Conti, H. R., & Gaffen, S. L. (2010) · Microbes and Infection · doi:10.1016/j.micinf.2010.03.013 · Cited by 154
“In 2004 (prior to the discovery of Th17 cells per se), the IL-17 receptor (IL-17RA, the common receptor for IL-17A and IL-17F) was reported to be necessary for host protection in the disseminated candidiasis mouse model [38], which was recently confirmed by an independent group [39].”
BackgroundInfluentialSelf-citationHou, W., Jin, Y.-H., Kang, H. S., & Kim, B. (2014) · Journal of Virology · doi:10.1128/jvi.00724-14 · Cited by 174
“7D), many of which may be activated in different settings by IL-6 or IL-17 (24, 25).”
BackgroundCho, K., Suh, J. W., Lee, K. H., Kang, J. L., & Woo, S. (2011) · International Immunology · doi:10.1093/intimm/dxr110 · Cited by 161
Diet-induced weight loss reduces colorectal inflammation: implications for colorectal carcinogenesis
Pendyala, S., Neff, L. M., Suárez‐Fariñas, M., & Holt, P. R. (2010) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.110.002683 · Cited by 167
Hajishengallis, G., & Lambris, J. D. (2016) · Immunological Reviews · doi:10.1111/imr.12467 · Cited by 153
Hu, Y., Ota, N., Peng, I., Refino, C. J., Danilenko, D. M., Caplazi, P., & Ouyang, W. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903614 · Cited by 153
Systemic effects of IL-17 in inflammatory arthritis
Beringer, A., & Miossec, P. (2019) · Nature Reviews Rheumatology · doi:10.1038/s41584-019-0243-5 · Cited by 163
Targeting the interleukin-17 immune axis for cancer immunotherapy
Vitiello, G. A., & Miller, G. (2020) · Journal of Experimental Medicine · doi:10.1084/jem.20190456 · Cited by 151
“IL-17A signaling strength, for example, is nearly 10–30 times as potent as IL-17F signaling, which may explain why IL-17A has been implicated in global immune function, while IL-17F participates more peripherally in mucosal immunity (Gaffen, 2009; Zhou et al., 2007).”
BackgroundFabre, T., Kared, H., Friedman, S. L., & Shoukry, N. H. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1400861 · Cited by 150
“The JNK pathway is one of the key fibrogenic and inflammatory pathways in the liver and can be activated by several cytokines, including IL-17A (20, 21, 34, 41).”
BackgroundSun, J., Zhang, S., Zhang, X., Zhang, X., Dong, H., & Qian, Y. (2015) · Journal of Neuroinflammation · doi:10.1186/s12974-015-0394-5 · Cited by 148
“Although IL-17A alone is a weak inducer of target genes, it has been shown to synergize with IL-1β, IL-22, IFN-γ, TNF-α, and other cytokines in vivo [11].”
BackgroundImmunobiology of Atherosclerosis: A Complex Net of Interactions
Herrero‐Fernández, B., Gómez-Bris, R., Somovilla-Crespo, B., & González, J. M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20215293 · Cited by 168
Effects of Interleukin 17 on the cardiovascular system
Robert, M., & Miossec, P. (2017) · Autoimmunity Reviews · doi:10.1016/j.autrev.2017.07.009 · Cited by 156
Nadeem, A., Ahmad, S. F., Al-Harbi, N. O., Fardan, A. S., El-Sherbeeny, A. M., Ibrahim, K. E., & Attia, S. M. (2017) · Cytokine · doi:10.1016/j.cyto.2017.05.018 · Cited by 147
Nakagawa, H., Niiro, H., & Ootaki, K. (2015) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2015.10.009 · Cited by 147
“The IL-17 cytokine family comprises six cytokines (IL-17A–IL-17F) and five receptors (IL-17RA17RE) [4].”
BackgroundCrystal structures of interleukin 17A and its complex with IL-17 receptor A
Liu, S., Song, X., Chrunyk, B. A., Shanker, S., Hoth, L. R., Marr, E. S., & Griffor, M. C. (2013) · Nature Communications · doi:10.1038/ncomms2880 · Cited by 168
van Baarsen, L. G. M., Lebre, M. C., van der Coelen, D., Aarrass, S., Tang, M. W., Ramwadhdoebé, T. H., Gerlag, D. M., & Tak, P. P. (2014) · Arthritis Research & Therapy · doi:10.1186/s13075-014-0426-z · Cited by 168
“In addition to IL-17RA, IL-17RC is required for signalling in response to IL-17A or IL-17F [10,11].”
BackgroundMucocutaneous IL-17 immunity in mice and humans: host defense vs. excessive inflammation
Li, J., Casanova, J.-L., & Puel, A. (2018) · Mucosal Immunology · doi:10.1038/mi.2017.97 · Cited by 146
IL-17-induced NF-κB Activation via CIKS/Act1
Sønder, S. U., Saret, S., Tang, W., Sturdevant, D. E., Porcella, S. F., & Siebenlist, U. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.199547 · Cited by 146
The role and modulation of CCR6+ Th17 cell populations in rheumatoid arthritis
Paulissen, S. M. J., van Hamburg, J. P., Dankers, W., & Lubberts, E. (2015) · Cytokine · doi:10.1016/j.cyto.2015.02.002 · Cited by 158
Su, Y., Huang, J., Zhao, X., Lu, H., Wang, W., Yang, X. O., Shi, Y., Wang, X., Lai, Y., & Dong, C. (2019) · Science Immunology · doi:10.1126/sciimmunol.aau9657 · Cited by 146
“In contrast to the findings in murine models, the IL-17 family receptors, particularly those cytokine-specific receptors, including IL-17RC (for IL-17A), IL-17RE (for IL-17C), and IL-17RB (for IL-25), as well as IL-17RD, were all greatly decreased compared with healthy controls, and only the common receptor, IL-17RA,…”
BackgroundInfluentialTh17 cells and IL-17 A—Focus on immunopathogenesis and immunotherapeutics
van den Berg, W. B., & McInnes, I. B. (2013) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2013.04.006 · Cited by 155
The role of Th17 cells in psoriasis
Li, B., Huang, L., Lv, P., Li, X., Liu, G., Chen, Y., Wang, Z., Qian, X., Shen, Y., Li, Y., et al. (2020) · Immunologic Research · doi:10.1007/s12026-020-09149-1 · Cited by 162
Papp, K. A., Reid, C., Foley, P. A., Sinclair, R. D., Salinger, D. H., Williams, G., Dong, H., Krueger, J. G., Russell, C. B., & Martin, D. A. (2012) · Journal of Investigative Dermatology · doi:10.1038/jid.2012.163 · Cited by 143
Th17‐associated cytokines promote human airway smooth muscle cell proliferation
Chang, Y., Al-Alwan, L. A., Risse, P., Halayko, A. J., Martin, J. G., Baglole, C. J., Eidelman, D. H., & Hamid, Q. A. (2012) · The FASEB Journal · doi:10.1096/fj.12-208033 · Cited by 152
“pharmacologic inhibitors against p38 MAPK, ERK1/2 MAPK, and NF- B pathways, as these pathways are known to be activated by Th17 cytokines (17, 24, 25).”
BackgroundMucocutaneous candidiasis: the IL-17 pathway and implications for targeted immunotherapy
Huppler, A. R., Bishu, S., & Gaffen, S. L. (2012) · Arthritis Research & Therapy · doi:10.1186/ar3893 · Cited by 143
“IL-17 activates NF-κB directly [64,65], as do the CLRs that bind fungal cell wall components and promote Th17 development.”
BackgroundSelf-citationEmerging role of IL-17 and Th17 cells in systemic lupus erythematosus
Martin, J. C., Baeten, D., & Josien, R. (2014) · Clinical Immunology · doi:10.1016/j.clim.2014.05.004 · Cited by 149
“The IL-17 receptors also constitute a distinct family of cytokine receptors which include five subunits: IL-17RA to IL-17RE [12].”
BackgroundInfluentialCandida albicans commensalism in the gastrointestinal tract
Neville, B. A., d'Enfert, C., & Bougnoux, M.-E. (2015) · FEMS Yeast Research · doi:10.1093/femsyr/fov081 · Cited by 139
“Other authors have also acknowledged that members of the IL-17 cytokine family, including IL-17A and IL-17F, are perhaps not essential for antifungal immunity; however, these authors have shown that IL-22, an IL-10 family cytokine that is also secreted by Th-17 cells, is required for early-stage fungal resistance in m…”
BackgroundInfluentialZhu, S., Pan, W., Shi, P., Gao, H., Zhao, F., Song, X., Liu, Y., Zhao, L., Li, X., Shi, Y., et al. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20100703 · Cited by 138
“Both IL-17 and Th17 cells have been found to contribute to the pathogenesis of many inflammatory autoimmune disorders in mouse models, including experimental autoimmune encephalomyelitis (EAE), collagen-induced arthritis (CIA), and inflammatory bowel disease (Nakae et al., 2003; Komiyama et al., 2006; Sato et al., 200…”
Immunopathobiology and therapeutic targets related to cytokines in liver diseases
He, Y., Hwang, S., Ahmed, Y. A., Feng, D., Li, N., Ribeiro, M., Lafdil, F., Kisseleva, T., Szabo, G., & Gao, B. (2021) · Cellular & Molecular Immunology · doi:10.1038/s41423-020-00580-w · Cited by 137
Axial spondyloarthritis: new advances in diagnosis and management
Ritchlin, C. T., & Adamopoulos, I. E. (2021) · BMJ · doi:10.1136/bmj.m4447 · Cited by 161
“78 79 Some evidence also highlighted interactions of IL-23 with immunoreceptors in human peripheral blood mononuclear cells, suggesting the multiple binding possibilities of IL-23:IL-23R signaling via protein assemblies.”
BackgroundTosello Boari, J., Amezcua Vesely, M. C., Bermejo, D. A., Ramello, M. C., Montes, C. L., Cejas, H., Gruppi, A., & Acosta Rodríguez, E. V. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002658 · Cited by 137
“to give raise to functional receptors [17].”
Chen, K., Eddens, T. J., Trevejo-Nuñez, G., Way, E. E., Elsegeiny, W. A. W., Ricks, D. M., Garg, A. V., Erb, C., Bo, M., Wang, T., et al. (2016) · Cell Host & Microbe · doi:10.1016/j.chom.2016.10.003 · Cited by 145
“However, IL-17C/IL-17RE signaling did not seem to contribute to the induction of chemokine responses and cytokines in response to intranasal IL-17, since neutrophil recruitment and the expression of Cxcl1, Cxcl2, Cxcl5 and Il6 did not change in Il17re−/− mice (Supplementary Fig.”
BackgroundSelf-citationInflammatory bowel disease: an impaired barrier disease
Jäger, S., Stange, E. F., & Wehkamp, J. (2012) · Langenbeck s Archives of Surgery · doi:10.1007/s00423-012-1030-9 · Cited by 158
“On the cytokine level, the induction is mediated by proinflammatory cytokines such as IL-1β (through NF-κB- and AP-1-dependent pathways) [74] and TNF-α or IL-17 [75].”
BackgroundTGF-β Receptor II Loss Promotes Mammary Carcinoma Progression by Th17-Dependent Mechanisms
Novitskiy, S. V., Pickup, M. W., Gorska, A. E., Owens, P., Chytil, A., Aakre, M., Wu, H., Shyr, Y., & Moses, H. L. (2011) · Cancer Discovery · doi:10.1158/2159-8290.cd-11-0100 · Cited by 136
Interleukin-17 in rheumatoid arthritis: Trials and tribulations
Taams, L. S. (2020) · The Journal of Experimental Medicine · doi:10.1084/jem.20192048 · Cited by 143
“IL-17RA is part of the receptor for IL-17A, IL17F, IL-17C, and IL-17E, and thus, IL-17RA blockade may affect signaling from all these cytokines (Gaffen, 2009).”
BackgroundRichter, F., Natura, G., Ebbinghaus, M., von Banchet, G. S., Hensellek, S., König, C., Bräuer, R., & Schaible, H. (2012) · Arthritis & Rheumatism · doi:10.1002/art.37695 · Cited by 135
“Because the intraarticular injection of IL-17 caused experimental hyperalgesia in a behavioral study (16), and because IL-17 receptor A (IL-17RA), one of the 5 IL-17 receptors (IL-17RA through IL-17RE) (3), is ubiquitously expressed, including by neurons of the central nervous system (17), in the present study we test…”
Xu, M., Li, J., Lee, Y., Wu, Y., Liu, K., Shi, Y., An, H., Zhang, J.-R., Wang, X., Lai, Y., et al. (2018) · Immunity · doi:10.1016/j.immuni.2018.03.019 · Cited by 140
Van Maele, L., Carnoy, C., Cayet, D., Songhet, P., Dumoutier, L., Ferrero, I., Janot, L., Erard, F., Bertout, J., Leger, H., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000115 · Cited by 132
Major Role of the IL17/23 Axis in Psoriasis Supports the Development of New Targeted Therapies
Bugaut, H., & Aractingi, S. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.621956 · Cited by 151
Gessner, M. A., Werner, J. L., Lilly, L. M., Nelson, M. P., Metz, A. E., Dunaway, C. W., Chan, Y. R., Ouyang, W., Brown, G. D., Weaver, C. T., et al. (2012) · Infection and Immunity · doi:10.1128/iai.05939-11 · Cited by 130
“IL17A is acknowledged to stimulate the antimicrobial immune effector functions of multiple cell types, including neutrophils, macrophages, and epithelial cells (12).”
BackgroundRegulation of epithelial immunity by IL-17 family cytokines
Pappu, R., Rutz, S., & Ouyang, W. (2012) · Trends in Immunology · doi:10.1016/j.it.2012.02.008 · Cited by 146
Wong, H., & Hoeffer, C. (2018) · Experimental Neurology · doi:10.1016/j.expneurol.2017.04.010 · Cited by 129
“IL-17A targets in the brain A. IL-17A receptors The IL-17 receptor (IL-17R) family consists of five related subunits (A-E) (Gaffen, 2009).”
BackgroundThe deubiquitinase A20 mediates feedback inhibition of interleukin-17 receptor signaling
Garg, A. V., Ahmed, M., Vallejo, A. N., Ma, A., & Gaffen, S. L. (2013) · Science Signaling · doi:10.1126/scisignal.2003699 · Cited by 128
“A20 inhibits the IL-17–dependent activation of MAPK signaling, particularly the c-Jun N-terminal kinase pathway In the IL-17 signaling pathway, TRAF6 is required for the activation of MAPKs (15).”
BackgroundSelf-citationGuo, X.-Z. J., Dash, P., Crawford, J. C., Allen, E. K., Zamora, A. E., Boyd, D. F., Duan, S., Bajracharya, R., Awad, W., Apiwattanakul, N., et al. (2018) · Immunity · doi:10.1016/j.immuni.2018.07.011 · Cited by 137
“In contrast, canonical IL-17A signaling proceeds through the nuclear factor-kB (NF-kB) pathway mediated by ACT1 (Gaffen, 2009), which results in the activation of the type 3 immune response traditionally associated with IL-17A.”
Th17 and Cognitive Impairment: Possible Mechanisms of Action
Cipollini, V., Anrather, J., Orzi, F., & Iadecola, C. (2019) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2019.00095 · Cited by 149
“However, because of their cytokine profile and ability to recruit other immune cell types, they are extremely pro-inflammatory and are implicated in the induction of several autoimmune diseases (Gaffen, 2009).”
BackgroundIL-17 is a neuromodulator of Caenorhabditis elegans sensory responses
Chen, C., Itakura, E., Nelson, G. M., Sheng, M., Laurent, P., Fenk, L. A., Butcher, R. A., Hegde, R. S., & de Bono, M. (2017) · Nature · doi:10.1038/nature20818 · Cited by 127
Effector T-cell subsets in systemic lupus erythematosus: update focusing on Th17 cells
Shin, M. S., Lee, N., & Kang, I. (2011) · Current Opinion in Rheumatology · doi:10.1097/bor.0b013e328349a255 · Cited by 136
The IL-17 Family Cytokines in Immunity and Disease
Pappu, R., Ramirez-Carrozzi, V. R., Ota, N., Ouyang, W., & Hu, Y. (2010) · Journal of Clinical Immunology · doi:10.1007/s10875-010-9369-6 · Cited by 143
“1), found on the surface of a multitude of target cells, including fibroblasts, keratinocytes, endothelial cells, epithelial cells, chondrocytes, and osteoblasts [12].”
BackgroundMüller, A., Hennig, A., Lorscheid, S., Grondona, P., Schulze‐Osthoff, K., Hailfinger, S., & Kramer, D. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1801377115 · Cited by 144
“IL-17A binds and activates the IL-17RA/IL-17RC receptor, followed by the recruitment of the adapter protein Act1 and the activation of MAPK and NF-κB (31).”
Background
Metadata
- Authors
- Gaffen, S. L.
- Affiliations
- University of Pittsburgh (US)
- Corresponding author
- Gaffen, Sarah L.
- ORCID
- Gaffen, Sarah L.
- Venue
- Nature reviews. Immunology
- Published
- 2009-07-03
- Volume
- 9
- Issue
- 8
- Pages
- 556-567
- ISSN
- 1474-1733 (ISSN-L)
- 1474-1741
- PMC
- PMC2821718
- OpenAlex
- W2020233428
- Cited by
- 1,475
- References
- 111
- Citations by year
- 2026: 66 · 2025: 87 · 2024: 57 · 2023: 76 · 2022: 80 · 2021: 118 · 2020: 76 · 2019: 96 · 2018: 81 · 2017: 92 · 2016: 108 · 2015: 91 · 2014: 107 · 2013: 89 · 2012: 90
- FWCI
- 7.31
- Type
- journal article
- Language
- en
- Update notices
- erratum (2009-08-07)
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature reviews. Immunology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01AR054389)
- National Institute of Dental and Craniofacial Research (R21DE018822)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Keywords
- IL-17A, IL-17RA, Th17 cells, cytokine signaling, signal transduction, innate and adaptive immunity, autoimmune disease, inflammatory pathology
- MeSH terms
- Animals, Autoimmune Diseases, T-Lymphocytes, Helper-Inducer, Humans, Inflammation, Signal Transduction, Cytokines, Interleukin-17, Receptors, Interleukin-17
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.